# Montelukast as Prophylaxis for Upper Respiratory Tract Infections in Children: a Randomised, Double-blind, Placebo-controlled Study

> **NCT00551382** · PHASE3 · UNKNOWN · sponsor: **Assaf-Harofeh Medical Center** · enrollment: 500 (estimated)

## Conditions studied

- Upper Respiratory Tract Infection

## Interventions

- **DRUG:** Muntelukast
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00551382
- **Lead sponsor:** Assaf-Harofeh Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-11
- **Primary completion:** 2009-12
- **Final completion:** 2010-06
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2010-03-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00551382

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00551382, "Montelukast as Prophylaxis for Upper Respiratory Tract Infections in Children: a Randomised, Double-blind, Placebo-controlled Study". Retrieved via AI Analytics 2026-08-01 from https://api.ai-analytics.org/clinical/NCT00551382. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*